Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block vs Wound Infiltration for Post-Nephrectomy Pain
NCT03496610Phase 4Completed
- Sponsor
- Duke University
- Start
- Jan 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Duke University. Primary endpoint: Opioid Consumption in Oral Morphine Milliequivalents at 24 hours. Started Jan 2021; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03496610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496610.